spiramycin (Sanofi)
Structured Review
Spiramycin, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spiramycin/spiramycin/pm41230266-26-0-3
Average 86 stars, based on 1 article reviews
Images
Related Articles
Infection:Article Title: Anaesthesiological and surgical considerations in a patient with ectopic adrenocorticotropic hormone syndrome Article Snippet: She started to receive Article Title: Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation. Article Snippet: The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs formulation on the parasite burden and histopathological changes in the liver, spleen and brain in experimentally infected mice.. Seventy male Swiss albino mice were classified into seven equal groups: healthy control (I), infected untreated control (II), infected group receiving CS NPs (III), spiramycin administered infected group (IV), infected group receiving spiramycinmetronidazole (V), infected receiving 400 mg/kg spiramycin-CS NPs (VI) and infected treated with spiramycinloaded CS NPs 100 mg/kg (VII).. All groups were inoculated intraperitoneally with 2500 T. gondii tachyzoites RH strain except the healthy control group. Article Title: Nanoemulsion of Spiramycin against Tachyzoites of Toxoplasma gondii , RH Strain: Preparation, Toxicology, and Efficacy Studies Article Snippet: Moreover, Activity Assay:Article Title: Anaesthesiological and surgical considerations in a patient with ectopic adrenocorticotropic hormone syndrome Article Snippet: She started to receive Article Title: Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation. Article Snippet: The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs formulation on the parasite burden and histopathological changes in the liver, spleen and brain in experimentally infected mice.. Seventy male Swiss albino mice were classified into seven equal groups: healthy control (I), infected untreated control (II), infected group receiving CS NPs (III), spiramycin administered infected group (IV), infected group receiving spiramycinmetronidazole (V), infected receiving 400 mg/kg spiramycin-CS NPs (VI) and infected treated with spiramycinloaded CS NPs 100 mg/kg (VII).. All groups were inoculated intraperitoneally with 2500 T. gondii tachyzoites RH strain except the healthy control group. Article Title: Nanoemulsion of Spiramycin against Tachyzoites of Toxoplasma gondii , RH Strain: Preparation, Toxicology, and Efficacy Studies Article Snippet: Moreover, Isolation:Article Title: Anaesthesiological and surgical considerations in a patient with ectopic adrenocorticotropic hormone syndrome Article Snippet: She started to receive Article Title: Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation. Article Snippet: The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs formulation on the parasite burden and histopathological changes in the liver, spleen and brain in experimentally infected mice.. Seventy male Swiss albino mice were classified into seven equal groups: healthy control (I), infected untreated control (II), infected group receiving CS NPs (III), spiramycin administered infected group (IV), infected group receiving spiramycinmetronidazole (V), infected receiving 400 mg/kg spiramycin-CS NPs (VI) and infected treated with spiramycinloaded CS NPs 100 mg/kg (VII).. All groups were inoculated intraperitoneally with 2500 T. gondii tachyzoites RH strain except the healthy control group. Article Title: Nanoemulsion of Spiramycin against Tachyzoites of Toxoplasma gondii , RH Strain: Preparation, Toxicology, and Efficacy Studies Article Snippet: Moreover, Biomarker Discovery:Article Title: Anaesthesiological and surgical considerations in a patient with ectopic adrenocorticotropic hormone syndrome Article Snippet: She started to receive Article Title: Remarkable histopathological improvement of experimental toxoplasmosis after receiving spiramycin-chitosan nanoparticles formulation. Article Snippet: The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs formulation on the parasite burden and histopathological changes in the liver, spleen and brain in experimentally infected mice.. Seventy male Swiss albino mice were classified into seven equal groups: healthy control (I), infected untreated control (II), infected group receiving CS NPs (III), spiramycin administered infected group (IV), infected group receiving spiramycinmetronidazole (V), infected receiving 400 mg/kg spiramycin-CS NPs (VI) and infected treated with spiramycinloaded CS NPs 100 mg/kg (VII).. All groups were inoculated intraperitoneally with 2500 T. gondii tachyzoites RH strain except the healthy control group. Article Title: Nanoemulsion of Spiramycin against Tachyzoites of Toxoplasma gondii , RH Strain: Preparation, Toxicology, and Efficacy Studies Article Snippet: Moreover, |
